Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.
The Fourth Cambridge Conference on Novel Agents in the Treatment of Lung Cancer was held in Cambridge, Massachusetts on September 29 to 30, 2006, to discuss ongoing clinical research of novel targeted agents for the treatment of non-small cell lung cancer, along with supportive basic and translational research into the molecular pathways implicated in cancer growth and resistance. New information, conclusions, and recommendations considered significant for the field by the program faculty are summarized below and presented at greater length in the individual articles and accompanying discussions that comprise the full conference proceedings.
Division of Hematology/Oncology, Massachusetts General Hospital, 55 Fruit Street, Yawkey, 7th Floor, Suite 7601, Boston, MA 02114, USA. tlynch@partners.org .
Thomas J
TJ
Lynch
Philip D
PD
Bonomi
Charles
C
Butts
Angela M
AM
Davies
Jeffrey
J
Engelman
Ramaswamy
R
Govindan
Roy S
RS
Herbst
John V
JV
Heymach
Bruce E
BE
Johnson
Renato G
RG
Martins
Roman
R
Perez-Soler
Gregory J
GJ
Riely
Alan B
AB
Sandler
Lecia V
LV
Sequist
Mark A
MA
Socinski
Kwok-Kin
KK
Wong
Carol S
CS
Hart
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents